CAS: 2052130-80-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | H3B-6545 REF: 3D-CHD13080CAS: 2052130-80-8 | Min. 95% | A consultar | Jue 20 Jun 24 |
 | H3B-6545 REF: TM-T11530LCAS: 2052130-80-8 | - - - | 113,00 €~2.368,00 € | Jue 11 Jul 24 |
H3B-6545
CAS:2052130-80-8
H3B-6545 is an investigational drug that is a CDK4/6 inhibitor. H3B-6545 has been shown to …
Fórmula:
C30H29F4N5O2
Pureza:
Min. 95%
Peso molecular:
567.6 g/mol
Ref: 3D-CHD13080
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
H3B-6545
CAS:2052130-80-8
H3B-6545 is an oral and selective antagonist of estrogen receptor covalent (SERCA).
Fórmula:
C30H29F4N5O2
Peso molecular:
567.58
Ref: TM-T11530L
| 25mg | 1.058,00 € | |
| 50mg | 1.395,00 € | |
| 100mg | 2.368,00 € |
Entrega estimada en Estados Unidos, el Jueves 11 de Julio de 2024
